BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical & Diagnostic

Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study

Summary of Study Outcomes ZIRCON Phase III study of Telix's investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) has met ...

November 07, 2022 | News

LUMC to Fund New Clinical Trial of Cynata's Cymerus™ MSCs in Kidney Transplantation

Cynata to collaborate with Leiden University Medical Center (LUMC) in the Netherlands, in a new clinical trial in patients who have received a kidne...

November 04, 2022 | News

Australia First in-human use of OncoRes Medical's cancer imaging system successful

OncoRes Medical today announces positive data from the first in-cavity use of its Quantitative Micro-Elastography (QME) Imaging System. The study, titled&n...

November 03, 2022 | News

Karyopharm and Menarini Group Announce Orphan Medicinal Product Designation from the European Commission for Selinexor for the Treatment of Myelofibrosis

Selinexor was granted orphan drug designation in MF by the U. S. Food and Drug Administration (FDA) in May 2022. Karyopharm is currently evaluating se...

November 02, 2022 | News

Thermo Fisher Scientific to Acquire The Binding Site Group

Complements Existing Specialty Diagnostics Offering with Established Technologies Delivering Strong Clinical Value for Patients in a Rapidly Growing...

November 01, 2022 | News

Aragen launches royalty-free CHO GS cell line development platform under RapTr2022

Aragen Life Sciences (Aragen), a leading Contract Research, Development, and Manufacturing Organization (CRDMO), with eight facilities across In...

October 28, 2022 | News

Siemens Healthineers and TVM Capital Healthcare collaborate to advance healthcare access in Southeast Asia

TVM Capital Healthcare, an emerging-markets focused healthcare private equity firm headquartered in Singapore and Dubai, with presence in&nb...

October 12, 2022 | News

China NMPA Approves Selpercatinib for the Treatment of Patients with RET-driven Lung and Thyroid Cancers

Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality med...

October 10, 2022 | News

Concord Medical Announces Changes in Management

Mr. Yaw Kong Yap has stepped down from his role as the chief financial officer and president of the Company due to reaching retirement age, effec...

October 03, 2022 | News

First Patient in New Zealand Dosed with Illuccix® - Telix's Prostate Cancer Imaging Agent

As Illuccix rolls out to positron emission tomography (PET) sites across the country, Mercy Radiology in Auckland became the first to administer ...

September 30, 2022 | News

Metabolon Expands Data Access Strategy to Include Health for Life in Singapore (HELIOS) Study

Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of research, diagnostic, therapeutic development, ...

September 28, 2022 | News

Merck Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor

NMS-293 is a next generation, orally available, brain-penetrant PARP1 selective inhibitor NMS-293 is currently studied in Phase I as monotherapy for the...

September 27, 2022 | News

Shandong Proton Center Celebrates Milestone in Delivering High-Quality Proton Treatment

Proton therapy can be used to treat many of the most common types of cancer. All radiotherapy, including proton and high energy X-rays (photon), destroys c...

September 26, 2022 | News

Menarini and SciClone to Develop and Commercialize Vaborem® in China to Treat Antimicrobial Resistant Infections

Vaborem®, a patented combination of meropenem and vaborbactam, is expected to address the rising prevalence of carbapenem-resistant Klebsiella pneumo...

September 21, 2022 | News

Stay Connected